QuidelOrtho
QDEL
$44.19
Share price
-0.02%
Change (1 day)
-48.41%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Cash on Hand
Cash on Hand as of March 2024 : $78.5 M
According to QuidelOrtho's latest financial reports the company has $78.5 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
QuidelOrtho - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | -51.51% |
| 2022-12-31 | $0.34 B | -58.36% |
| 2021-12-31 | $0.82 B | 69.1% |
| 2020-12-31 | $0.48 B | 828.36% |
| 2019-12-31 | $52.77 M | 20.78% |
| 2018-12-31 | $43.69 M | 21.09% |
| 2017-12-31 | $36.08 M | -78.71% |
| 2016-12-31 | $0.16 B | -11.47% |
| 2015-12-31 | $0.19 B | -4.69% |
| 2014-12-31 | $0.20 B | 2295.03% |
| 2013-12-31 | $8.38 M | -43.54% |
| 2012-12-31 | $14.85 M | -75.78% |
| 2011-12-31 | $61.33 M | 803.54% |
| 2010-12-31 | $6.78 M | -92.7% |
| 2009-12-31 | $93 M | 60.6% |
| 2008-12-31 | $57.9 M | 27.3% |
| 2007-12-31 | $45.48 M | 24.2% |
| 2006-12-31 | $36.62 M | 4.85% |
| 2005-12-31 | $34.93 M | -3.83% |
| 2004-12-31 | $36.32 M | 41.73% |
| 2003-12-31 | $25.62 M | 780.65% |
| 2002-12-31 | $2.91 M | -14.31% |
| 2001-12-31 | $3.39 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $7.25 B | 9,135.67% | 🇺🇸 USA |
 Becton Dickinson BDX | $3.17 B | 3,944.59% | 🇺🇸 USA |
 Danaher DHR | $7.03 B | 8,856.69% | 🇺🇸 USA |
 PerkinElmer
PKI | $2.46 B | 3,035.22% | 🇺🇸 USA |
 OraSure Technologies OSUR | $0.26 B | 236.02% | 🇺🇸 USA |
 Meridian Bioscience VIVO | $81.45 M | 3.76% | 🇺🇸 USA |